59 sixes, 129 fours: Mumbai teenager scores 1009 in 323 balls!

Bengaluru, Feb 28: “Those who struggle to come up can understand people’s problems better. Yediyurappa is one such leader who has reached this position after a struggle,’’ said former chief minister Siddaramaiah, in praise of Chief Minister BS Yediyurappa, who celebrated his 78th birthday on Thursday in Bengaluru.

Siddaramaiah was the only non-BJP leader on the dais, who not only attended the event, but was present throughout. He released a coffee table book, ‘A Leader who Saw Tomorrow’, on Yediyurappa’s life and achievements, compiled by The New Indian Express.

Dwelling on the political spectrum and human relationships, Siddaramaiah said, “Our ideologies are different, but that is limited to politics. Politics should not come between personal relationships.’’ Recalling his association with Yediyurappa, Siddaramaiah said that in 1983, he and Yediyurappa had entered the Assembly for the first time.

“Yediyurappa did not become chief minister just like that. It took years of struggle and hard work. We both have many similarities — neither of us came from political backgrounds. We came up through struggle and those who come from such backgrounds understand people,’’ he said.

Siddaramaiah said that it was Yediyurappa who first became chief minister, and he had reached the post only five years later. “I am five years younger than him, maybe that is the reason,’’ he said on a lighter note. Yediyurappa has become chief minister four times, but I have been chief minister only once, he added. He also spoke about how Yediyurappa had played an important role in bringing the BJP to power in the state, the party’s first government in South India. “Very few leaders know the pulse of the state and Yediyurappa is one among them,’’ he said.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.